• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High-dose romiplostim for donor-type aplasia.

作者信息

Hosokawa Kohei, Imi Tatsuya, Yokota Takafumi, Tada Yuma, Maruyama Hiroyuki, Sugimori Naomi, Ishiyama Ken, Yamazaki Hirohito, Miyamoto Toshihiro, Nakao Shinji

机构信息

Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, 920-8641, Ishikawa, Japan.

Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.

出版信息

Ann Hematol. 2025 Jun 12. doi: 10.1007/s00277-025-06448-1.

DOI:10.1007/s00277-025-06448-1
PMID:40504447
Abstract
摘要

相似文献

1
High-dose romiplostim for donor-type aplasia.高剂量罗米司亭治疗供者型再生障碍性贫血。
Ann Hematol. 2025 Jun 12. doi: 10.1007/s00277-025-06448-1.
2
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.采用供体外周血淋巴细胞对骨髓移植后复发白血病进行异基因细胞治疗。
Exp Hematol. 1995 Dec;23(14):1553-62.
3
[Recovery of vascular niche in bone marrow by donor derived endothelial progenitor cells after allogeneic bone marrow transplantation in mice].[小鼠异基因骨髓移植后供体来源的内皮祖细胞对骨髓血管龛的修复作用]
Zhonghua Xue Ye Xue Za Zhi. 2012 Aug;33(8):623-7.
4
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.成人血液系统恶性肿瘤的骨髓与外周血异基因造血干细胞移植。
Cochrane Database Syst Rev. 2024 Nov 7;11(11):CD010189. doi: 10.1002/14651858.CD010189.pub3.
5
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.采用供体外周血细胞和重组人白细胞介素-2进行异基因细胞治疗，以治疗异基因骨髓移植后的白血病复发。
Blood. 1996 Mar 15;87(6):2195-204.
6
[Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France].[法国罗米司亭和利妥昔单抗治疗成人原发性免疫性血小板减少症的每位缓解者成本]
Transfus Clin Biol. 2014 May;21(2):85-93. doi: 10.1016/j.tracli.2014.03.007. Epub 2014 May 3.
7
[Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].[供体调节性T细胞对小鼠异基因骨髓移植后移植物抗宿主病及造血重建的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):547-52.
8
[Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].[同种反应性自然杀伤细胞在小鼠MHC半相合骨髓移植中的作用]
Zhonghua Xue Ye Xue Za Zhi. 2006 Feb;27(2):82-6.
9
Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.供体CD4 + T细胞产生肿瘤坏死因子α对移植物抗宿主病早期促炎事件有显著影响。
Exp Hematol. 2007 Jan;35(1):155-63. doi: 10.1016/j.exphem.2006.09.012.
10
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.
Blood. 1997 Nov 15;90(10):4206-11.

本文引用的文献

1
Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.罗米司亭治疗艾曲泊帕难治性再生障碍性贫血有效：一项回顾性研究的结果。
Int J Hematol. 2020 Dec;112(6):787-794. doi: 10.1007/s12185-020-02971-1. Epub 2020 Sep 2.
2
High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.高剂量罗米司亭可加速对艾曲泊帕难治的再生障碍性贫血患者的血液学恢复。
Leukemia. 2021 Mar;35(3):906-909. doi: 10.1038/s41375-020-0950-6. Epub 2020 Jul 3.
3
Relapse of Aplastic Anemia with Majority Donor Chimerism (Donor-Type Aplasia) Occurring Late after Bone Marrow Transplantation.
骨髓移植后迟发的多数供者嵌合体（供体型再生障碍性贫血）复发。
Biol Blood Marrow Transplant. 2020 Mar;26(3):480-485. doi: 10.1016/j.bbmt.2019.11.010. Epub 2019 Nov 13.
4
Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.依鲁替尼治疗亲缘单倍体造血干细胞移植后难治性血小板减少症有效且安全。
Bone Marrow Transplant. 2019 Aug;54(8):1310-1318. doi: 10.1038/s41409-019-0435-2. Epub 2019 Jan 21.
5
Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.
Bone Marrow Transplant. 2019 Jul;54(7):1129-1132. doi: 10.1038/s41409-018-0420-1. Epub 2019 Jan 10.
6
Immune-Mediated Hematopoietic Failure after Allogeneic Hematopoietic Stem Cell Transplantation: A Common Cause of Late Graft Failure in Patients with Complete Donor Chimerism.同种异体造血干细胞移植后免疫介导的造血衰竭：完全供者嵌合体患者晚期移植物衰竭的常见原因。
Biol Blood Marrow Transplant. 2018 Jan;24(1):43-49. doi: 10.1016/j.bbmt.2017.08.018. Epub 2017 Aug 30.
7
Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.艾曲泊帕用于儿童异基因造血干细胞移植后血小板恢复继发性失败
Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.13017. Epub 2017 Jun 27.
8
Late graft rejection and second infusion of bone marrow in children with aplastic anaemia.
Br J Haematol. 1999 Jan;104(1):186-8. doi: 10.1046/j.1365-2141.1999.01159.x.